These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9681451)

  • 1. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum.
    Stephans SE; Whittingham TS; Douglas AJ; Lust WD; Yamamoto BK
    J Neurochem; 1998 Aug; 71(2):613-21. PubMed ID: 9681451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity.
    Stephans S; Yamamoto B
    Neuroscience; 1996 Jun; 72(3):593-600. PubMed ID: 8861054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex.
    Stephans SE; Yamamoto BY
    Brain Res; 1995 Nov; 700(1-2):99-106. PubMed ID: 8624733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats.
    Quinton MS; Yamamoto BK
    Psychopharmacology (Berl); 2007 Aug; 193(3):341-50. PubMed ID: 17458543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity.
    Chan P; Di Monte DA; Luo JJ; DeLanney LE; Irwin I; Langston JW
    J Neurochem; 1994 Jun; 62(6):2484-7. PubMed ID: 8189253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.
    Tata DA; Yamamoto BK
    Synapse; 2008 May; 62(5):325-36. PubMed ID: 18288648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
    Zhu JP; Xu W; Angulo JA
    Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
    Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1/6N mouse.
    Cosi C; Chopin P; Marien M
    Brain Res; 1996 Oct; 735(2):343-8. PubMed ID: 8911677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
    Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
    J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic stress on methamphetamine-induced dopamine depletions in the striatum.
    Matuszewich L; Yamamoto BK
    Ann N Y Acad Sci; 2004 Dec; 1032():312-4. PubMed ID: 15677439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of methamphetamine on the production of free radicals and oxidative stress.
    Yamamoto BK; Zhu W
    J Pharmacol Exp Ther; 1998 Oct; 287(1):107-14. PubMed ID: 9765328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW; Bailey SL
    Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
    Gough B; Pereira FC; Fontes Ribeiro CA; Ali SF; Binienda ZK
    Neurochem Int; 2014 Oct; 76():109-13. PubMed ID: 25049173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
    Cass WA; Walker DJ; Manning MW
    Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo.
    Finnegan KT; Taraska T
    J Neurochem; 1996 May; 66(5):1949-58. PubMed ID: 8780022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats.
    Huang NK; Wan FJ; Tseng CJ; Tung CS
    Neuroreport; 1997 May; 8(8):1883-5. PubMed ID: 9223070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lubeluzole on the methamphetamine-induced increase in extracellular glutamate and the long-term depletion of striatal dopamine.
    Wallace TL; Vorhees CV; Gudelsky GA
    Synapse; 2001 May; 40(2):95-101. PubMed ID: 11252020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.